|Year : 2012 | Volume
| Issue : 1 | Page : 19-22
Depression and Alzheimer disease ( a risk factor or a prodrome)
Hoda Salama, Tarek Molokhia, Hazem Maarouf, Hesham Sheshtawy
Department of Neuropsychiatry, Faculty of Medicine, Alexandria University, Alexandria, Egypt
|Date of Submission||21-Jul-2011|
|Date of Acceptance||15-Sep-2011|
|Date of Web Publication||6-Jun-2014|
Department of Neuropsychiatry, Faculty of Medicine, Alexandria University, Alexandria
Source of Support: None, Conflict of Interest: None
The number of elderly individuals in the population is steadily increasing. One of the well known problems in the elderly is cognitive impairment. Alzheimer disease is the most common cause of cognitive impairment. Another health problem in this age group that can present with cognitive impairment is depression. Several controversies exist regarding the relationship between depression and Alzheimer disease.
This work aims at studying whether depression can be a risk factor for future development of Alzheimer disease.
Patients and methods
Twenty patients with Alzheimer disease in the outpatient clinic were asked about their history of depression and the presence of depression at the onset of illness.
One unmarried woman (5%) had a history of depression. Seven patients (35%) had depression at the onset of illness.
The current study supports the hypothesis that depressed mood is not a risk factor for future development of Alzheimer disease. Further studies are needed to assess the relationship between cognitive symptoms of depression and future development of Alzheimer disease.
Keywords: Alzheimer disease risk factor, depression, prodrome
|How to cite this article:|
Salama H, Molokhia T, Maarouf H, Sheshtawy H. Depression and Alzheimer disease ( a risk factor or a prodrome). Egypt J Psychiatr 2012;33:19-22
|How to cite this URL:|
Salama H, Molokhia T, Maarouf H, Sheshtawy H. Depression and Alzheimer disease ( a risk factor or a prodrome). Egypt J Psychiatr [serial online] 2012 [cited 2022 Aug 13];33:19-22. Available from: http://new.ejpsy.eg.net/text.asp?2012/33/1/19/133925
| Introduction|| |
The number of elderly people in the population is steadily increasing. In 1900, the percentage of elderly individuals older than 65 years was 5%. In 2003, the percentage increased to 15%, and it is expected to be about 24% in 2030. Elderly individuals suffer from several social and medical problems. One of the most common medical problems suffered by them and faced by physicians dealing with them is cognitive decline (Steffens et al., 2009).
One of the most well-known causes of progressive cognitive decline in the elderly is dementia. Dementia has a serious impact on the affected person, his/her caregiver(s), and on the community as a whole. The most common cause for dementia is Alzheimer disease (AD). Five percent of elderly individuals above 65 years suffer from AD. This percentage increases to 30% in those above 85 years. It is expected that 81 million people will suffer from AD in 2040 (Alzheimer’s Association, 2009).
Anticholinesterases were introduced as a pharmacological treatment for dementia with an evidenced efficacy in delaying the progress and sometimes improving the course of the disease (Dickerson et al., 2007; Traykov et al., 2007; Wu et al., 2009). Therefore, early detection and treatment of dementia is of considerable importance (Milisen et al., 2006; Belleville et al., 2008). This has led to the recognition of mild cognitive impairment (MCI) (Dierckx et al., 2007). MCI is the intervening zone between normal aging and dementia. MCI is considered by many authors as the prodrome of dementia (Brodaty et al., 2003; Rosenberg and Lyketsos, 2008; Werner and Korczyn, 2008).
There are several causes for cognitive decline in the elderly other than dementia. Examples for these causes are systemic illness, previous psychotic illness, intake of medications, and depression (Steffens et al., 2009).
Depression is a very common problem among the elderly population. Prevalence of clinically significant depression among them is about 10%, which means that depression is more common than dementia (Potter and Steffens et al., 2007; Hattori, 2008, 2009). Depression and dementia have serious consequences; yet, their treatment and prognosis are totally different. Therefore, differentiation between depression and dementia is of considerable importance (Chertkow et al., 2008; Steffens, 2008; Thomas and O’Brien, 2008).
In the real clinical practice, this differentiation is sometimes very difficult. This difficulty is due to the following reasons:
- Cognitive decline is a common presentation for depression in the elderly (known as pseudodementia).
- Depressive symptoms are common in actual dementia.
- Sometimes, depression is the prodrome of dementia.
Treating depression with antidepressants markedly improves cognitive decline, but the cognition rarely becomes normalized (Wright and Persad, 2007; Gagliardi, 2008; Steffens and Potter, 2008).
The question now is can we consider depression as a risk factor for future development of AD?
| Aim|| |
This work aims at studying whether depression can be a risk factor for future development of AD.
| Patients|| |
This study included 20 patients with AD in the outpatient clinic. They were chosen according to the following inclusion and exclusion criteria:
- Age above 60 years.
- Presence of previous psychotic illness.
- Mental subnormality.
- Presence of severe systemic illness (e.g. chronic advanced liver disease, chronic advanced renal disease).
- Presence of previous neurological disease (e.g. stroke, infection, and epilepsy).
| Methods|| |
Written consent was taken from the patients (or their relatives) before participation in the study.
Clinical assessment was performed with special emphasis on the following:
- Main presenting manifestations.
- Previous history of depression.
- Depression at onset of illness.
| Results|| |
The present study was carried on 20 patients with AD. The number of women was 12 (60%), whereas the number of men was eight (40%). The mean age of the studied group (in years) was 79.65±3.13.
Recent amnesia was the first symptom that propelled the caregivers of the patient to seek medical advice in four cases (20%), whereas agitation alone was responsible for another four cases (20%) to start to seek medical advice; sleep problems alone were responsible for three cases. The majority (nine cases; 45%) sought medical advice for both agitation and sleep problems ([Figure 1]).
Only one female patient (5%) reported a history of depression ([Figure 2]). Of the 20 patients, seven (35%) reported suffering from depression at the onset of illness ([Figure 3]).
| Discussion|| |
Is depression a risk factor for developing future dementia (including AD) or is depression a prodrome of AD? Answering this question is important because if depression is a risk factor for AD, effective treatment of depression can, theoretically, decrease the probability of developing AD in the future.
The number of women in the studied group was 12 (60%), whereas the number of men was eight (40%). The mean age was 79.65±3.13 years. These findings were consistent with that of Benson et al. (2005).
According to the current study on AD patients, only one unmarried woman (5%) reported a history of depression ([Figure 2]). Also, in this group, seven patients (35%) reported suffering from depression at the onset of illness ([Figure 3]). These findings support the fact that depression is not a risk factor for AD. Also, these findings support the theory of considering depression as a prodrome of AD under some, but not all, conditions. Accordingly, we can see cases of depression alone, cases of depression at the start that culminate in AD, and finally we can see AD that did not start from depression. Thus, we can see depression and dementia from a dimensional perspective.
Several cross-sectional and longitudinal epidemiological studies have found an association between late-life depressive symptoms and subsequent cognitive decline, including MCI and probable dementia (Barnes, et al., 2006; Geda et al., 2006), but it remains uncertain whether the presence of depressive symptoms is a risk factor or a prodrome or a consequence of a pathological cognitive decline or a part of the pathological process.
A meta-analysis (Ownby et al., 2006) has suggested that a history of depression approximately doubles the risk of developing AD, supporting the fact that depression can indicate a risk of future occurrence of AD. However, recent large prospective cohort studies (Panza et al., 2008a, 2008b; Becker et al., 2009) have failed to show that depressed mood is a risk factor for MCI and dementia.
In the Baltimore Longitudinal Study of Aging and the Personnes Agée QUID study, the presence of premorbid depressive symptoms increased the risk of later development of dementia, especially AD, but only in men, suggesting a predisposition based on sex (Fuhrer et al., 2003; Dal Forno et al., 2005). This was also reported in the Framingham Heart study (Saczynski et al., 2010).
In The Women’s Health Initiative Memory Study (WHIMS) (Goveas et al., 2011), a cohort of postmenopausal women aged 65–79 years at study baseline who met the screening cutoff for depressive disorder, a greater risk of subsequent MCI and incident dementia was found after a mean follow-up of 5.4 years than in those who were not depressed. These findings remained significant after adjusting for multiple potential confounding variables, including demographic characteristics, lifestyle variables, cardiovascular risk factors, presence of cerebrovascular disease, antidepressant use, baseline cognitive function (as measured using the modified mini-mental state examination (3Ms)), and prior use and current prescription of hormone therapy. The participants who were depressed had approximately twice the hazard of developing MCI and probable dementia.
Benson et al. (2005) compared the performance of the mini-mental state examination (MMSE) total score and item scores in separating four groups of elderly (55–85 years of age) individuals: normal controls, patients with MCI, patients with mild AD, and patients with depression. They concluded that the MMSE effectively separates those with mild AD from the other three groups and MCI from normal aging, but it is relatively ineffective in separating normal elderly individuals from those with depression and individuals with MCI from those with depression. Measures other than the MMSE may need to be implemented to evaluate the mental status to more effectively separate MCI from depression and depression from normal aging. Was the use of 3Ms an effective choice for adjusting the confounding factor of baseline cognitive function in WHIMS? It is a question that needs further research.
Accordingly, the findings of the current study were consistent with that of the Italian Longitudinal study on Aging and the study by Becker and colleagues. In contrast, these findings were inconsistent with that of the Baltimore Longitudinal Study of Aging, the Personnes Agée QUID study, and WHIMS.
This is not a prospective study. Therefore, we cannot ignore the recall bias factor with regard to the history of depression. In contrast, answering ‘yes’ to the question of ‘did you (your parent) have a past history of depression?’ usually denotes the presence of previous depressed mood rather than a full-blown picture of depressive disorder.
Accordingly, we can observe that studies that comment on depressed mood (Italian Longitudinal study on Aging, Becker et al. (2009), and the current study) did not find any relation with future development of dementia. In contrast, studies that commented on depressive symptoms (Baltimore Longitudinal Study of Aging, the Personnes Agée QUID study, and WHIMS) found a positive relation with future development of dementia. It seems that the presence of memory symptoms of depressive disorder is a risk for development of future dementia rather than just the presence of depressed mood. In contrast, because the neurodegenerative changes seen in AD precede the clinical diagnosis by several years, these memory symptoms of depressive disorder may be the earliest manifestation of this neurodegenerative disease, suggesting that depressive disorder with memory symptoms was actually a prodrome of AD. This hypothesis needs to be further studied.
| References|| |
|1.||. Alzheimer’s disease facts and figures. Alzheimer’s Demen. 2009;5:234–270 |
|2.||Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease and mild cognitive impairment: findings from the cardiovascular health study. Arch Gen Psychiatry. 2006;63:273–280 |
|3.||Becker JT, Chang YF, Lopez OL, Dew MA, Sweet RA, Barnes D, et al. Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry. 2009;17:653–663 |
|4.||Belleville S, Sylvain-Roy S, de Boysson C, Ménard MC. Chapter 23 Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res. 2008;169:365–375 |
|5.||Benson AD, Slavin MJ, Tran TT, Petrella JR, Doraiswamy PM. Screening for early Alzheimer’s disease: is there still a role for the Mini-Mental State Examination? Prim Care Companion J Clin Psychiatry. 2005;7:62–67 |
|6.||Brodaty H, Luscombe G, Anstey KJ, Cramsie J, Andrews G, Peisah C. Neuropsychological performance and dementia in depressed patients after 25-year follow-up: a controlled study. Psychol Med. 2003;33:1263–1275 |
|7.||Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ. 2008;178:1273–1285 |
|8.||Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex and risk for Alzheimer’s disease. Ann Neurol. 2005;57:381–387 |
|9.||Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry. 2007;64:1443–1450 |
|10.||Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I. Differentiation between mild cognitive impairment, Alzheimer’s disease and depression by means of cued recall. Psychol Med. 2007;37:747–755 |
|11.||Fuhrer R, Dufouil C, Dartigues JF. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID study. J Am Geriatr Soc. 2003;51:1055–1063 |
|12.||Gagliardi JP. Differentiating among depression, delirium and dementia in elderly patients. Virtual Mentor. 2008;10:383–388 |
|13.||Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, et al. Depression, apolipoprotein E genotype and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol. 2006;63:435–440 |
|14.||Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the women’s health initiative memory study. J Am Geriatr Soc. 2011;59:57–66 |
|15.||Hattori H. Depression in the elderly. Jpn J Geriatr. 2008;45:451–461 |
|16.||Hattori H. Elderly depression and depressive state with Alzheimer’s disease. Nippon Rinsho. 2009;67:835–844 |
|17.||Milisen K, Braes T, Fick DM, Foreman MD. Cognitive assessment and differentiating the 3 Ds (Dementia, Depression, Delirium). Nurs Clin North Am. 2006;41:1–22 |
|18.||Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis and metaregression analysis. Arch Gen Psychiatry. 2006;63:530–538 |
|19.||Panza F, Capurso C, D’Introno A, Colacicco AM, Zenzola A, Menga R, et al. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry. 2008a;23:726–734 |
|20.||Panza F, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, et al. Depressive symptoms, vascular risk factors and mild cognitive impairment: the Italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2008b;25:336–346 |
|21.||Potter GG, Steffens DC. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist. 2007;13:105–117 |
|22.||Rosenberg PB, Lyketsos CG. Mild cognitive impairment: searching for the prodrome of Alzheimer’s disease. World Psychiatry. 2008;7:72–78 |
|23.||Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology. 2010;75:35–41 |
|24.||Steffens DC. Separating mood disturbance from mild cognitive impairment in geriatric depression. Int Rev Psychiatry. 2008;20:374–381 |
|25.||Steffens DC, Potter GG. Geriatric depression and cognitive impairment. Psychol Med. 2008;38:163–175 |
|26.||Steffens DC, McQuoid DR, Potter GG. Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. J Geriatr Psychiatry Neurol. 2009;22:52–61 |
|27.||Thomas AJ, O’Brien JT. Depression and cognition in older adults. Curr Opin Psychiatry. 2008;21:8–13 |
|28.||Traykov L, Rigaud AS, Cesaro P, Boller F. Neuropsychological impairment in the early Alzheimer’s disease. Encephale. 2007;33:310–316 |
|29.||Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical and social issues. Clin Intervent Aging. 2008;3:413–420 |
|30.||Wright SL, Persad C. Distinguishing between depression and dementia in older persons: neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol. 2007;20:189–198 |
|31.||Wu XS, Cheng HD, Wang K. Memory monitoring in mild cognitive impairment. Nat Med J China. 2009;89:1037–1040 |
[Figure 1], [Figure 2], [Figure 3]